“The potential to bring a major treatment to patients this year, while simultaneously pushing the boundaries to develop new therapies, fills me with anticipation and purpose. Driven by the unwavering dedication of the Biometrics Programming team, the impact of our work, and our collective passion for helping patients with rare diseases, I feel ready for a transformational 2025.”